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Abstract
The control of cellular signaling cascades is of utmost importance in regulating the immune response.
Exquisitely precise protein-protein interactions and chemical modification of substrates by enzymatic catalysis
are the fundamental components of the signals that alert immune cells to the presence of a foreign antigen. In
particular, the phosphorylation events induced by protein kinase activity must be spatially and temporally
regulated by specific interactions to maintain a normal and effective immune response. High resolution
structures of many protein kinases along with supporting biochemical data are providing significant insight
into the intricate regulatory mechanisms responsible for controlling cellular signaling. The Tec family kinases
are immunologically important kinases for which regulatory details are beginning to emerge. This review
focuses on bringing together structural insights gained over the years to develop an understanding of how
domain interactions both within the Tec kinases and between the Tec kinases and other signaling molecules
control immune cell function.
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Summary
The control of cellular signaling cascades is of utmost importance in regulating the immune
response. Exquisitely precise protein-protein interactions and chemical modification of substrates
by enzymatic catalysis are the fundamental components of the signals that alert immune cells to
the presence of a foreign antigen. In particular, the phosphorylation events induced by protein
kinase activity must be spatially and temporally regulated by specific interactions to maintain a
normal and effective immune response. High resolution structures of many protein kinases along
with supporting biochemical data are providing significant insight into the intricate regulatory
mechanisms responsible for controlling cellular signaling. The Tec family kinases are
immunologically important kinases for which regulatory details are beginning to emerge. This
review focuses on bringing together structural insights gained over the years to develop an
understanding of how domain interactions both within the Tec kinases and between the Tec
kinases and other signaling molecules control immune cell function.
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Introduction
It can be said that protein kinases control the currency of signal transduction. Protein kinases
catalyze the transfer of the γ-phosphate of adenosine triphosphate (ATP) to specific amino
acid side chains creating a cascade of chemical information that elicits a cellular response.
The creation of transiently phosphorylated amino acid side chains directs specific protein
interactions and controls catalytic activity within the complexity of the cell. It is therefore
not unexpected that precise regulation of kinase activity is vital in maintaining normal
cellular function and that loss of specificity and/or loss of catalytic control can profoundly
affect cell fate. Exquisitely controlled protein interactions and conformational changes
within the multi-domain structures of these enzymes are emerging as the switches that
control kinase activity (1–8).
Of the 518 protein kinases identified in humans, ~17% are tyrosine kinases that can be
broadly classified into receptor tyrosine kinases and non-receptor tyrosine kinases (9). The
Src family kinases and the Tec family kinases constitute the two largest families of non-
receptor tyrosine kinases (10–12). The well-studied Src kinase family includes nine different
proteins that mediate signaling in a number of different cell types (13–15). The regulation of
Src activity and Src-mediated signaling has been extensively explored and provides a point
of comparison for other tyrosine kinase families. Our interest has focused on the Tec
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kinases, enzymes that are primarily expressed in hematopoietic cells where they function
downstream of several immune cell receptors (10,11,16).
The Tec family of non-receptor tyrosine kinases consists of five members: interleukin-2
(IL-2)-inducible T-cell kinase (Itk), Bruton’s tyrosine kinase (Btk), Tec, Txk, and Bmx
(bone marrow tyrosine kinase gene on chromosome X) (10,17). The critical role of these
immunological tyrosine kinases is underscored by the fact that mutations within Btk are
associated with a severe B-cell immunodeficiency, X-linked agammaglobulinemia (XLA) in
humans and X-linked immunodeficiency (XID) in mice (18). XLA afflicts around 1 in
200,000 individuals and is characterized by an increased susceptibility to bacterial infections
(18). The physiological roles of the Tec kinases have been extensively reviewed elsewhere
and are not explored here (10–12,16,19–21). Instead, we focus on the structural features of
the Tec kinases with an emphasis on gaining insight into how conformational switches and
domain interactions control Tec kinase activity during signaling.
The domain architecture of the Tec kinases (Fig. 1A) is similar to that of the Src family
kinases. Both kinase families contain a single Src homology 3 (SH3) domain and Src
homology 2 (SH2) domain followed by the catalytic kinase domain [also referred to as a Src
homology 1 (SH1) domain] (10). Unlike the Src kinases, the Tec kinases (with the exception
of Bmx), also contain a pleckstrin homology (PH) domain followed by a Tec homology
(TH) domain at the amino-terminus. The TH domain consists of a region unique to the Tec
kinases (the Btk motif) followed by one or more proline-rich regions. Another significant
difference between the Tec and Src kinases is that the Tec kinases lack the key regulatory
tyrosine that is present in the C-terminal tail of Src kinases (10). Since the identification of
the first mammalian Tec kinase member (Tec) 18 years ago (22), the absence of a Src-like
regulatory tail (and the concomitant absence of the critical tyrosine residue) has suggested
that the Tec kinase regulatory apparatus differs significantly from that of the related Src
kinases (23). From this standpoint, a number of investigators have probed the structural
features of the Tec kinases with the goal of defining the interactions and conformational
switches that control Tec kinase signaling and subsequent immune cell function.
With a structure of a full-length Tec family kinase still eluding crystallographers, we begin
the discussion of Tec kinase structure with an overview of the individual domains.
Numerous structures have been reported for each of the individual Tec kinase domains (Fig.
1B-E). PDB entries can be found for the Btk PH domain (pdb: 1btk, 1b55, 2z0p, 1bwn) (24–
26); the Btk motif is included in these PH domain structures but has also been solved
separately for Itk and Bmx (pdb: 2e6i and 2ys2). The SH3 domains of Itk, Btk, and Tec have
each been solved (pdb: 1qly, 1awx, 2rna, 1awj, 2yuq, 1gl5) (27–30); SH2 domains
structures for Itk, Btk, Bmx, and Txk are reported (pdb: 2etz, 2dm0, 2ge9, 2ekx, 1luk, 1lun)
(31, 32). Structures for the isolated kinase domains of Btk and Itk are known (pdb: 1k2p,
1snx, 1sm2, 1snu) (33, 34). These modular domains are found in large numbers of signaling
proteins and the general functions of each isolated domain have been well characterized. In
the following paragraphs, we provide a brief description of each domain and describe
classical ligand-binding functions. Information about how each of these domains participates
in immune cell signaling is summarized as well. In the second part of this review, we
discuss recent molecular level work aimed at elucidating how these modular domains act in
concert to control Tec kinase activity and specificity during signaling.
Overview of the individual Tec kinase domains
PH domain
The structure and function of the PH domain have been reviewed (35–38). In contrast to the
lipid modified Src kinases that are constitutively present on cellular membranes, Tec kinases
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(with the exception of Txk) are transiently recruited to the cell membrane via their N-
terminal PH domain upon receptor activation (39–42). PH domains are lipid-binding
domains consisting of ~120 amino acids (37,43). Although PH domains share limited amino
acid sequence homology, their structural folds are strikingly similar (37). The crystal
structure of the isolated Btk PH domain R28C mutant as well as the structures of the Btk
wildtype and a gain-of-function E41K PH domain mutant in complex with inositol 1,3,4,5-
tetrakisphosphate (IP4) have been solved (24,25). The Btk PH domain structure is similar to
other PH domains and consists of a seven-stranded β-sandwich connected by loops of
variable length at one end and capped off by a C-terminal α-helix at the other (25) (Fig. 1B).
One notable feature of the Btk PH domain structure is the presence of a long insertion in the
loop connecting β-strands 5 and 6. This extended loop is not well defined in the Btk PH
domain crystal structure nor is it present in the other Tec family members. The Btk motif
consists of another long loop that folds back onto itself and packs against β-strands 5–7 of
the PH domain. The motif is stabilized by a zinc ion that is coordinated by three conserved
cysteines and one histidine residue (25).
The lipid-binding properties of the Btk and Itk PH domain have been extensively studied in
vitro (39,44–46). Both show a preference for D-3 inositol phosphate lipids, with a Kd of 40
nM measured for the binding of the Btk PH domain to IP4 (39,44). Similar to other PH
domains, the Btk PH domain is electrostatically polarized (Fig. 2) with positively charged
residues in the β1-β2 and β3-β4 loops forming a charged surface that mediates binding of
IP4 (25). Deletion of the Tec kinase PH domain or mutations in the PH domain that disrupt
lipid binding abolish translocation to the cell membrane (44,47). Another piece of evidence
that the PH domain plays an important role in signaling comes from the numerous XLA-
causing mutations that have been identified in the Btk PH domain of XLA-afflicted patients
(18). Most of these XLA-causing mutations either directly disrupt inositol lipid binding or
change the electrostatic properties of the lipid-binding site (24,25).
The localization and activity of the Tec family kinases are dependent on the activity of the
lipid kinase phosphoinositide 3-kinase (PI3K) (39,41,42). PI3K generates
phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)P3] by the phosphorylation of
phosphatidylinositol 4,5-bisphosphate. Decreasing the intracellular levels of PtdIns(3,4,5)P3
by the overexpression of phosphatases, such as the inositol 5-phosphatase SHIP (SH2-
domain-containing inositol-5-phosphatase), or the use of PI3K inhibitors (such as
Wortmanin), decreases membrane recruitment of the Tec kinases (42,48,49). SHIP1 and
SHIP2 have also been shown to be negative regulators of Tec, and a direct interaction
between SHIP1 and SHIP2 and the Tec SH3 domain has been demonstrated (49). In a
corresponding manner, the deficiency of the inositol 3-phosphatase PTEN (phosphatase and
tensin homologue) in Jurkat cells leads to elevated levels of PtdIns(3,4,5)P3, which is
responsible for the constitutive membrane localization of Itk in these cells (50).
Membrane association of the Tec kinases may not be a simple matter. A recent report by
Huang et al. (51) has shown that membrane recruitment of Itk is dependent on cellular levels
of the soluble inositol lipid IP4. Mice defective in IP3 3-kinase B (ItpkB), the enzyme that
generates IP4 from IP3, have severe defects in the Itk signaling pathway and lack mature T
cells (51). It is proposed that IP4 may bind to the Itk PH domain and induce a conformation
that has a higher affinity for both IP4 and PtdIns(3,4,5)P3. The higher concentrations of
PtdIns(3,4,5)P3 at the site of receptor activation would then displace IP4. An alternate
hypothesis is based on the observation that the Itk PH domain oligomerizes (51). Binding of
IP4 by one PH domain subunit could induce conformational changes in an associated PH
domain that result in increased affinity for the headgroup of PtdIns(3,4,5)P3. Regardless of
its effect on ligand binding, PH domain oligomerization itself is notable, and we discuss
other possible functional consequences of Itk PH domain self-association below.
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SH3 domain
The SH3 domain structure and function has been reviewed (52,53). The SH3 fold consists of
two three stranded β-sheets juxtaposed at right angles (Fig. 1C). Conserved aromatic
residues within the primary sequence of the SH3 domain form a hydrophobic groove on the
surface that binds proline-rich ligands (30,54,55). In particular, a conserved tryptophan
residue protrudes into the aromatic binding cleft and plays a critical role in binding of
proline-rich ligands. This tryptophan residue is the target for traditional loss of function SH3
domain mutation and examination of such a mutant in full length Itk showed normal
catalytic activity in vitro (56). In contrast, Itk carrying the mutated SH3 domain does not
permit IL-2 production in T cells (56). Together these data suggest that the role of the Itk
SH3 domain is primarily in mediating protein-protein interactions rather than regulating
catalytic activity. Although a variety of SH3 domain ligands have been identified for Tec
kinases (57–61), the precise mechanism by which these interactions regulate in vivo function
of Tec kinases remains unclear.
The SH3 domains of the Tec kinases also contain a conserved tyrosine residue (Y180 in Itk,
Y223 in Btk) (56,62–64) that is the site of autophosphorylation. Mutation of this tyrosine
has been shown to have varying effects in vivo with the outcome appearing dependent on the
assay system used. For example, the Btk Y223F mutation increases the oncogenic activity of
a Btk E41K mutant, while the same Btk Y223F mutation was found to restore calcium
signaling in a Btk-deficient B-cell line (62,65). Similarly, the Itk Y180F mutant has been
shown to only partially restore extracellular signal-regulated kinase (ERK) phosphorylation
in Itk-deficient T cells (56). Autophosphorylation within the SH3 domain has no impact on
the in vitro catalytic activity of the Tec kinases (56,62,66). Thus, the functional
consequences of Tec kinase autophosphorylation in vivo are presumed to be due to altered
ligand interacts rather than changes in intrinsic kinase activity (56,66).
This model is consistent with the location of the autophosphorylation site within the
aromatic binding pocket of the SH3 domain (Fig. 3). Itk Y180 sits at the edge of the SH3
proline-binding pocket, and nuclear magnetic resonance (NMR) chemical shift mapping of
an Itk SH3 Y180E mutant (chosen to mimic the phosphorylated SH3 domain) shows
chemical shift perturbations (indicative of structural perturbations) that extend well into the
ligand-binding pocket of the SH3 domain (66)(Fig. 3). Consistent with structural
perturbations on the ligand-binding pocket, the Itk SH3 Y180E mutant exhibits diminished
affinity for a proline-rich ligand, while the affinity for a different, non-canonical ligand is
increased (66). Autophosphorylation of the Btk SH3 domain also induces ligand-specific
effects (59). Phosphorylated Btk SH3 domain leads to a decreased affinity for Wiskott-
Aldrich syndrome protein (WASP), whereas binding to c-Cbl remains unchanged (59).
Thus, autophosphorylation of the Tec SH3 domains seems to fine tune binding affinity in a
ligand-specific manner with no direct effect on catalytic activity.
Adjacent to the SH3 domain in each of the Tec family kinases is at least one proline-rich
sequence that corresponds to the classical SH3 ligand sequence (10,54,67). A number of
SH3-containing interacting partners of the Tec kinases have been identified that likely bind
to these proline stretches during signaling (68,69). As well, SH3/proline interactions within
the same molecule (either in an intramolecular or intermolecular sense) have been well
studied among the Tec kinases. The first efforts along these lines involved the adjacent
proline-rich region and SH3 domain of Itk (55). That work as well as a follow up study (70)
show that the SH3/proline ligand interaction within Itk occurs exclusively in an
intramolecular fashion. In contrast, the SH3/proline interaction within the nearly identical
region of Txk/Rlk occurs only in the intermolecular sense (70). To complicate these
observations further, Btk and Tec contain two consecutive proline-rich segments adjacent to
their SH3 domain. The results of detailed NMR and biophysical studies of the Btk and Tec
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proline-proline-SH3 fragments reveal a complex equilibrium where the proline stretches
interact both inter- and intra-molecularly with the SH3 domain (28,71,72).
These intra- and inter-molecular SH3/proline interactions could certainly compete with
exogenous ligands to regulate the activity and localization of Tec kinases (55,73). However,
despite the enormous amount of attention paid to SH3 domains in general and the Tec
family SH3 domains specifically, we still lack a precise understanding of how the SH3
domain integrates Itk and related kinases into their respective signaling cascades. As a final
example of the complexity in these systems, we can consider the observed translocation of
both Itk and Btk to the nucleus following receptor activation (74,75). The SH3 domain
appears to play a role as deletion of the SH3 domain disrupts the export of Btk from the
nucleus, thereby causing nuclear sequestration (74).
SH2 domain
The SH2 domain structure and function have been reviewed (76–79). SH2 domains consists
of ~100 amino acids and are well characterized phosphotyrosine peptide-binding modules
(79). Like the numerous other SH2 structures solved, the Tec kinase SH2 domains fold into
a centralβ-sheet that is flanked by two α-helices (Fig. 1D). The phosphopeptide ligand binds
perpendicularly to the central β-sheet in a two-prong manner with the phosphotyrosine (pY)
and the residue in the pY+3 position making critical contacts with the SH2 domain
(31,32,80). Phosphopeptide binding is mediated by a conserved arginine residue (R265 in
Itk) in the pY pocket of the SH2 domain, while ligand specificity is conferred by residues in
the specificity pocket which coordinate the peptide residue in the pY+3 position (80) (Figs
1D and 4B).
The Syk family kinases create phosphorylation sites on SH2 domain-containing leukocyte
phosphoprotein of 76 kDa (SLP-76) and linker for activation of T cells (LAT) for binding of
the Tec SH2 domains (81–84). The interaction between the Itk SH2 domain and the
phospho-SLP-76/LAT complex is required for proper Itk activity in vivo (68,85,86). The
traditional loss-of-function mutation within the Itk SH2 domain [mutation of the conserved
arginine (R265) responsible for binding the ligand phosphotyrosine] therefore impedes
membrane localization and subsequent activation (85). Thus, the PH domain-mediated
membrane recruitment described above, while necessary for Tec kinase activation, is not
sufficient (40,85). The SH2 domain plays an equally critical role.
The structures of the isolated Tec kinase SH2 domains have been thoroughly examined
(31,32). The Itk SH2 domain is unique among the Tec family SH2 domains, as it adopts two
distinct conformational states (Fig. 4). The observed conformational heterogeneity is due to
cis/trans prolyl isomerization about a single imide bond within the domain (32), a structural
phenomenon that is still somewhat unique among folded proteins (87). Prolyl isomerization
arises from the nearly equal energies of the cis and trans imide bond conformers.
Isomerization is typically slow (msec to sec) due to the energetic barrier of interconversion
(on the order of 14–24 kcal/mol) (88).
For short, proline-containing peptides, cis/trans prolyl isomerization is nearly always
observed because of the lack of restraints on the flexible polypeptide chain. Instead, the
prolyl imide bonds in most folded proteins are restricted (by the tertiary structure) into either
the trans or cis conformations; the lower energy trans imide bond conformer predominates
in structures of folded proteins. Thus, the proline-induced conformational heterogeneity
within the folded Itk SH2 domain is of considerable interest from a structural biology point
of view. Finally, the fact that NMR spectroscopy was used to solve the solution structure of
the Itk SH2 domain greatly facilitated identification of prolyl isomerization in this system.
In solution, the polypeptide chain readily samples an ensemble of conformations including
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cis/trans imide bond conformations. Given the preponderance of protein structures solved
by x-ray crystallography in the protein database, we should question whether prolyl
isomerization is a more common structural feature of proteins than currently recognized. Is
protein crystallization itself impeding our ability to fully appreciate important dynamical
features of the protein backbone?
The structural consequences of prolyl isomerization in the Itk SH2 domain are not limited to
the local sequence surrounding the proline. In fact, prolyl isomerization around the single
imide bond induces structural differences across nearly half of the domain surface (Fig. 4B).
This extensive effect is likely responsible for the fact that the two imide bond conformers of
the Itk SH2 domain exhibit different ligand binding properties (89). The SH2 domain
containing the trans imide bond conformer has a higher affinity for the classical
phosphotyrosine-containing SH2 ligand than does the cis imide bond conformer. The
structure of the trans Itk SH2 domain complexed with a phosphotyrosine peptide (80)
suggests that the preferential binding of the Itk SH2 trans conformer arises from the pre-
organized nature of the specificity pocket (BG loop) in the trans form compared to the cis
conformer (80). It is interesting to note that the phosphopeptide ligand is some distance from
the proline switch (Fig. 4B) and that the structure of the phosphotyrosine-binding pocket
itself is unaffected by prolyl isomerization. Thus, phosphopeptide discrimination of trans
versus cis likely arises from differential contacts in the pY+3 specificity pocket.
What then is the role of the cis imide bond containing SH2 conformer? Early work identified
a novel ligand for the Itk SH2 domain (90), and subsequent analysis clarified that the cis
imide bond conformer mediates the interaction (89). The novel SH2 ligand is the Itk SH3
domain; Itk SH3 binds with higher affinity to the cis Itk SH2 domain than the trans (89).
The interaction between the Itk SH2 and SH3 domains is phosphotyrosine independent and
does not involve a canonical proline-rich ligand. Thus, both the SH3 and SH2 binding
partners in this complex exploit recognition elements that do not fit the well-defined ligand-
binding properties of these common domains. The structure of the Itk SH2 domain in the cis
conformer complexed with the Itk SH3 domain has recently been solved (Severin A, Fulton
DB, Andreotti AH, manuscript in preparation, pdb code: 2k79) and reveals how the cis
imide bond containing SH2 domain is the preferred ligand for the SH3 domain (Fig. 5). The
conformationally heterogeneous proline does not make direct contact to the SH3 domain but
rather stabilizes the large CD loop structure in the SH2 domain to make extensive contacts
with the Itk SH3 domain. This structure combined with that of the trans SH2 domain
complexed with phosphopeptide (80) reveal how a prolyl switch can alter a protein
interaction surface to achieve selectivity (90). Again, it remains to be determined how many
other examples of this type of molecular recognition exist, and a first step will be to
accurately predict or determine the presence of proline-driven conformational switches in
other folded proteins.
The functional significance of prolyl isomerization within Itk is of great interest (91). It is
discussed further below, but it is notable that Itk is the only member of the Tec family that
contains the conformationally heterogeneous proline in the SH2 domain. As well, Itk is the
only kinase in the family that does not self-associate in an intermolecular fashion via the
SH3/proline-region interaction; instead the cisSH2/SH3 interaction occurs inter-molecularly,
while the proline-SH3 region of Itk exclusively associates intra-molecularly. In fact, the first
study to examine Itk SH3 domain accessibility (55) predates characterization of the Itk SH3/
SH2 interaction, and so those early data can now be better interpreted. In addition to the
proline/SH3 intramolecular interaction, the interaction of the Itk SH3 domain with the cis Itk
SH2 domain also masks the SH3-binding cleft and would affect binding of exogenous
ligands to the Itk SH3 domain. Thus, all of the Tec kinases form inter-molecularly
associated species, albeit through distinct domain-domain interactions. We revisit the
Joseph and Andreotti Page 6
Immunol Rev. Author manuscript; available in PMC 2010 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
importance of intermolecular Tec kinase self-association again in the context of catalytic
control.
Kinase domain
The kinase domain structure and function have been reviewed (3,23,92). The kinase domain
contains the catalytic center of the kinase molecule. Tyrosine kinase domains have a
conserved structure consisting of a small N-terminal lobe composed of five β strands and
one prominent helix: the C-helix (3,93) (Fig. 1E). The larger C-terminal lobe consists
mainly of helices. ATP binds in a deep cleft between the two lobes of the kinase. The
activation loop runs between the two lobes of the kinase domain and provides a platform for
the binding of the peptide substrate (3,94,95). Kinase activation is accompanied by a
tyrosine phosphorylation step that induces large conformational changes in the activation
loop (3). For the Tec family kinases Itk and Btk, activation is achieved by phosphorylation
of the activation loop tyrosines Y511 and Y551, respectively (96,97), by Src family kinases
(10,98). Based on work in other kinases, the activation loop is collapsed into the active site
and blocks access to the substrate prior to this activating phosphorylation step. Upon
phosphorylation of the activation loop tyrosine, the loop moves away from the active site
permitting the substrate to bind. This is accompanied by an inward movement of the C-helix
that enables a conserved glutamate (E445 in Btk) on the C-helix to form an ion pair with and
orient a conserved lysine (K430 in Btk) within the N-terminal lobe of the kinase (3) (Fig. 6).
In the crystal structure of the unphosphorylated, inactive kinase domain of Btk (34), the
activation loop adopts an unexpected, extended conformation that does not block the active
site but instead is rather similar to that of the activated Src family kinase Lck (34) (Fig. 6).
However, in the same structure, the C-helix is not optimally positioned, consistent with the
‘inactive’ state of the Btk kinase domain. The distance between the key Btk residues E445
and K430 is 10 A, unlike the 3 A distance found for the corresponding pair in active kinases
(34) (Fig. 6). Btk E445 instead forms a hydrogen bond with the side chain of R544, which
prevents the formation of the E445:K430 hydrogen bond that in turn prevents repositioning
of the C-helix. Phosphorylation on Btk Y551 is thought to engage R544 in an interaction
with the phosphate group of pY551, which then releases E445 to interact with K430 and
form an active kinase conformation. In fact, this hydrogen bond switch has been proposed as
a general mechanism for the activation of Tec kinases (34).
The crystal structures of the phosphorylated and unphosphorylated forms of the Itk kinase
domain in complex with the inhibitor staurosporine have also been solved (33).
Interestingly, the Itk kinase domain crystallized in the same conformation in both the
phosphorylated and unphosphorylated forms of the kinase (33). The authors call into
question the activating role of phosphorylation on Itk Y511 as well as the activation
mechanism proposed earlier for Tec kinases based on the unphosphorylated Btk kinase
structure (34). However, inhibitor binding has been shown to cause considerable
rearrangements within the active site of other kinases (93,99), and in fact, the distance
between the conserved lysine within the N-terminal lobe (Itk K390) and conserved
glutamate on the C-helix (Itk E405) is ~ 7 A in both Itk structures (33). It is possible
therefore that the conformation observed for the Itk kinase domain is a consequence of
staurosporine binding rather than an indication that the active site of this particular kinase
follows a different set of rules to achieve activation. Moreover, the role of the non-catalytic
domains adjacent to the kinase domain needs to be considered to fully understand the
mechanisms of regulation at work within the Tec kinase family.
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The regulatory domains in context: their role in activation
When the Tec kinases were first identified (22,100–104), it was immediately obvious that
they lack the C-terminal regulatory tail that plays such a critical role in controlling the
catalytic activity of the Src kinases (10). Another difference between the Src and Tec
kinases emerged from detailed biochemical analyses; enzymatic assays using a panel of Itk,
Btk and Tec constructs revealed that the isolated Tec family kinase domains are far less
active than the corresponding full-length enzymes (33,105,106). In contrast, deletion of the
regulatory SH3 and SH2 domains from the Src kinase yields a significantly more active
kinase domain (23,107,108). How then do the non-catalytic domains of Itk and the other Tec
kinases exert this positive influence on the activity of the neighboring kinase domain? Posed
in a different way, why are the isolated Tec family kinase domains almost inactive toward
their substrates?
Without a structure of any full-length Tec kinase we need to look to related molecules for
which structural data exist. In addition to the Src and Tec kinases, the C-terminal Src kinase
(Csk) shares the SH3-SH2-kinase domain cassette. Csk also lacks the C-terminal regulatory
tail of the Src kinases (109), and, like the Tec family, the isolated kinase domain of Csk is
100 times less active than the full-length enzyme containing the SH3 and SH2 domains
(110). These similarities with the Tec kinase family suggest that Csk may serve as a useful
model for understanding Tec kinase regulation.
A crystal structure of full-length, active Csk is available and shows that the SH3 and SH2
domains sit at the top of the N-terminal lobe of the kinase domain (109) (Fig. 7). The linkers
between the SH3 and SH2 domains and between the SH2 and Csk kinase domains run
nearly parallel to each other and make extensive contacts with the N-terminal lobe of the
Csk kinase domain (Fig. 7). The C-helix adopts the classical ‘active’ kinase configuration in
this structure likely stabilized by contacts between the N-terminal kinase lobe and the
parallel linkers (109). Indeed, a tryptophan residue in the linker between the SH2 and kinase
domains of Csk plays a critical role in stabilizing the active state. Mutation of this single Trp
residue inactivates the Csk kinase (109). The SH3 and SH2 domains (and the intervening
linker regions) become uncoupled from the kinase domain in this mutant, permitting the C-
helix to move outward disrupting side chain contacts within the active site that are necessary
for maintaining activity (110–115).
The available crystal structures of the Tec family kinase domains do not contain any of these
regulatory components; neither SH3 nor SH2 domain is present nor are the intervening
linkers. In particular, the SH2/kinase domain linker region that contains the conserved
tryptophan residue is absent in the Itk constructs used for crystallization. Thus, using
available structures we cannot assess structural similarities and differences between Itk and
Csk. Nevertheless, an overlay of the Itk structures that are available with the Csk structure
suggests a mutational strategy to pin down the regulatory mechanism of Itk (106).
Like Csk, the tryptophan residue in the linker preceding the Itk kinase domain is required to
couple the Itk regulatory domains to the kinase domain. Point mutation of this conserved
Trp (W355 in Itk) reduces the activity of full-length Itk, Tec, and Btk to the low level
associated with the isolated kinase domains in each case (106). Itk also contains a
methionine at position 410 that is present in the Itk structure and is uniquely conserved
within the Tec family kinases. The structural superposition with Csk (Fig. 7) suggests that
Met 410 at the end of the C-helix makes direct contact with the critical tryptophan side chain
and thus stabilizes the active conformation of the C-helix. Indeed, mutation of Met 410 in
the context of full length Itk abolishes kinase activity, suggesting a critical role for this side
chain as well (106). Thus, interactions between the Itk linker and the N-terminal kinase lobe
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likely impinge on the C-helix stabilizing Itk in the active conformation. Removing the
stabilizing contacts [either by point mutation of critical residues (106) or by wholesale
deletion of the linkers and regulatory domains of Itk (105,106)] leads to a complete loss of
catalytic activity as the C-helix reverts back to its inactive orientation. Thus, a structural
picture of the active configuration of the Tec kinases is beginning to emerge. The SH2-
kinase linker region is particularly important and must be available to make specific contacts
with the N-terminal lobe of the kinase domain. This activation mechanism is
consideredagain after discussion of possible mechanisms that serve to inactivate Tec kinase
activity.
Substrate recognition: how is specificity controlled?
Once activated, the Tec kinases phosphorylate a tyrosine within their own SH3 domain as
well as exogenous downstream substrates. Recognition of appropriate substrates in the
context of complex signaling pathways remains an area of active research especially for the
protein tyrosine kinases (116,117). While localization of proteins in distinct regions of the
cell can restrict access to certain substrates, it is not sufficient to explain the specificity of
these enzymes in vivo (118–120).
The crystal structures of kinases in complex with peptide substrates have shed considerable
light on the mechanism by which kinases recognize their substrates (116,121). The peptide
substrate binds to the C-terminal lobe of the kinase forming an anti-parallel β sheet with the
activation loop (116,121) (Fig. 8). Some kinases have exhibited sequence preferences for
their substrates with selective residues at the P 1, P+1, and P+3 positions relative to the
substrate tyrosine (116). The insulin receptor kinase (Irk), for example, has a substrate
sequence preference of YMXM (122). The crystal structure of the Irk in complex with a
peptide substrate containing this sequence shows that the methionine residues are located in
hydrophobic pockets on the surface of the Irk kinase domain (Fig. 8), thereby explaining its
strict sequence preference (121). However, not all kinases exhibit such strict sequence
requirements. Instead, substrate specificity can be achieved via remote substrate docking
interactions (119).
By definition, substrate docking occurs when a specific region on the substrate (remote from
the site to be phosphorylated) binds to the kinase domain on a site distinct from the active
site (119). This mechanism, though commonly described for serine/threonine kinases, has
been less commonly described for the tyrosine kinases. It has been suggested that one reason
for the difference is that serine/threonine kinases evolved to develop docking sites as they
sometimes lack interaction modules such as the SH3 and SH2 domains that are often present
in tyrosine kinases (118). That said, a specific docking interaction has been described for the
tyrosine kinase Csk (123–125), and it is in fact likely that most kinases make use of docking
interactions to ensure specificity.
Our attention was drawn to the possibility that the Tec tyrosine kinases might also exploit a
substrate docking mechanism based on simple sequence comparison of the two established
Itk substrates in T cells. As already described, Itk autophosphorylates Y180 within its own
SH3 domain. As well, Itk phosphorylates a specific tyrosine residue (Y783) in the
exogenous substrate phospholipase Cγ1 (PLCγ1). The Y180 autophosphorylation site is
contained with the LVIALY180DYQTN sequence, and the sequence surrounding the Y783
phosphorylation site in PLCγ1 is RNPGFY783VEANP. It is immediately evident that local
sequence similarities are lacking (particularly at the P+1 and P+3 positions; the P 1 positions
are both hydrophobic but for PLCγ1 it is aromatic), and so the Itk kinase active site must
achieve specificity for these target tyrosines by an alternative means.
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Another significant clue that the Tec kinases employ a substrate docking mechanism to
achieve specific substrate phosphorylation comes from the surprising observation that none
of the full length Itk, Tec, or Btk enzymes phosphorylate the autophosphorylation sites
within their isolated SH3 domains in vitro (Y180, Y187 and Y223 for Itk, Tec and Btk
respectively) (126). Efficient phosphorylation is only observed when these substrates
contain both the SH3 domain (which carries the target tyrosine residue) and the neighboring
SH2 domain (126). In complete agreement with these observations, phosphorylation of the
PLCγ1 substrate by Itk follows the same pattern. Phosphorylation efficiency for Y783
increases dramatically for PLCγ1 substrates that include the PLCγ1 SH2 domain adjacent to
the target tyrosine at position 783 (126). Detailed examination of this phenomenon reveals
that the SH2 domain serves a specific docking role for Tec kinase substrate phosphorylation
(126). The SH2 domains of Itk substrates bind directly to the Itk kinase domain. This
binding is independent of classical pY binding (mutation of the conserved arginine in the pY
pocket has no impact on the docking interaction or substrate phosphorylation) but docking
rather involves a distinct face of the SH2 domain. Moreover, Itk substrate phosphorylation is
efficiently inhibited by the presence of free SH2 domain in the kinase assay (126).
To fully understand the Tec kinase docking mechanism, these biochemical data (126) need
to be translated into a molecular level understanding of just how kinase domain and SH2
domain come together to facilitate and control target phosphorylation. Clearly, in this vein, a
high-resolution structure of the docked complex will be invaluable. In lieu of such a
structure, results of mutagenesis experiments can guide model building to more fully
characterize the docking motifs on both the enzyme and substrate.
Two protein surfaces need to be identified; the Itk kinase domain presents a docking site that
binds to a specific surface of the Itk and PLCγ1 SH2 domains. The kinase docking sites may
or may not be the same for each substrate. For both, however, there is evidence that binding
occurs outside of the kinase active site, as binding of the isolated SH2 domains to the Itk
kinase domain does not affect the phosphorylation kinetics of a short peptide substrate
(126). This suggests that SH2 docking onto the Itk kinase domain surface does not impede
access to the active site. The SH2 side of each kinase substrate interaction has been
identified by direct mutagenesis (Min L, Joseph RE, Andreotti AH, unpublished data). For
both the Itk SH2 domain and the PLCγ1 SH2 domain, a cluster of basic residues is necessary
to mediate substrate phosphorylation. Mutation of specific SH2 residues that are remote
from the site of phosphorylation in each substrate (and outside of the classical pY binding
pockets) leads to complete loss of Y180 or Y783 phosphorylation by Itk.
Given these emerging clues, we can begin to visualize how the Tec kinases achieve
specificity via docking interactions with the SH2 domains of their substrates (Figs 9 and 10).
The basic nature of the SH2 binding site prompted examination of the surface exposed
residues on the Itk kinase domain. A cluster of acidic side chains is evident on the N-
terminal lobe of the kinase domain. Simple juxtaposition of the PLCγ1 SH2 domain and the
Itk kinase domain that places the charged surfaces together shows that the C-terminus of the
PLCγ1 SH2 domain points directly toward the kinase active site (Fig. 9). Since Y783 is
located about 20 residues beyond the C-terminus of the SH2 domain, one can readily
envision how this docking arrangement could facilitate appropriate placement of this target
tyrosine into the Itk active site. As well, this model would be consistent with the data that
show SH2 binding to the Itk kinase domain does not inhibit phosphorylation of a short
peptide substrate; the Itk active site is not obstructed by the SH2 binding (126). Another
feature of this docking model is that the phospholigand-binding pocket of the SH2 domain
of PLCγ1 remains accessible for ligand binding; this is consistent with biochemical data
showing that the phosphotyrosine binding pocket is not involved in the SH2/kinase docking
interaction (126, Min L, Joseph RE, Andreotti AH, unpublished data).
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The SH2-mediated docking interaction that leads to autophosphorylation of Y180 within Itk
can be considered separately. For this substrate, the target tyrosine is embedded in the
confines of the SH3 domain tertiary structure. In an effort to generate a model of Y180
docked into the active site of the Itk kinase domain, a different kinase/substrate structure
was used as a template (66). The Itk kinase domain was superimposed with the Irk structure
[solved in complex with a tyrosine containing peptide substrate and the non-hydrolyzable
ATP analog, adenylyl imidodiphosphate (AMP-PNP)] (Fig. 8). The Y180 side chain within
the Itk SH3 domain was then aligned with the peptide substrate tyrosine (Fig. 10). In this
simple model, the SH3 domain fits extremely well into the Itk kinase active site (Fig. 10B).
Moreover, like the Irk substrate and other kinase substrate complexes for which structures
have been solved (116,121), the β strand in the SH3 domain encompassing Itk Y180 (βA
using standard SH3 domain nomenclature) runs anti-parallel to the Itk kinase activation loop
(Fig. 10A).
Biochemical data show that this SH3 domain does not get phosphorylated on Y180 without
a direct docking interaction between the adjacent SH2 domain and the Itk kinase domain
(126). Moreover, Itk autophosphorylation occurs 'in cis'; the Itk kinase domain mediates
phosphorylation of its own SH3 domain rather than an SH3 domain from another Itk
molecule (66). Building on this information and the available enzyme/substrate complex
model (Fig. 10), we can consider that the Itk SH2 domain is covalently linked to the C-
terminus of the Itk SH3 domain and to the N-terminus of the Itk kinase domain via the linker
that makes activating contacts across the back of the N-terminal kinase lobe (106)(Fig. 7).
These covalent restraints together with the observation that the Itk SH2 domain interacts
directly with the Itk kinase domain allows us to suggest that the Itk SH2 domain docks onto
the N-terminal lobe of the kinase domain (Fig. 10). The resulting quaternary arrangement of
the Itk SH3-SH2-casette would be distinct from that previously observed for other tyrosine
kinases such as Src. The model also predicts that the Itk regulatory domains exhibit
sufficient flexibility to adopt the docked conformation required for autophosphorylation.
Prior to and post autophosphorylation, the Itk SH3 domain must move away from the kinase
active site.
The proposed docking sites for substrate SH2 domains illustrated in Fig 9 and 10 need to be
considered in light of data suggesting that, like Csk (Fig. 7), the SH2 domain of Itk is
situated just above the active site and in contact with the N-terminal kinase lobe when Itk is
active. During Itk autophosphorylation, we wonder whether the Itk SH2 domain serves two
simultaneous roles, both activating the Itk kinase domain and positioning the SH3 domain
into the active site. After autophosphorylation, the SH3 domain would swing out of the
active site, and the SH2 domain would remain in its activating position. In considering Itk-
mediated phosphorylation of the exogenous substrate PLCγ1, the same question needs to be
answered. Does the PLCγ1 SH2 domain dock onto the Itk kinase domain in a manner that
allows simultaneous activating interactions between Itk kinase domain and Itk SH2 domain?
Perhaps the PLCγ1 SH2 domain docks onto a shared surface of the Itk SH2 and kinase
domains in a manner that maintains the active Itk conformation (6). Or alternatively, does
the PLCγ1 SH2 domain transiently displace the Itk SH2 domain keeping Itk in its active
conformation during catalysis? Confirmation of these various models awaits further
mutagenesis and structure determination of multi-domain fragments or full-length Tec
kinases. Also, the C-terminal lobe of the Itk kinase domain has not been ruled out as the
substrate-docking site; indeed the other tyrosine kinase for which substrate docking has been
described is Csk (123–125). In that case, the substrate (Src) docks onto the larger C-terminal
lobe to position the Src tail into the Csk active site (125).
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Inactivating the Tec kinases the ‘off switch’
Of equal importance to the activation mechanisms of protein kinases is negative regulation.
Catalytic activity must be negatively regulated both prior to and following activation. Layers
of regulatory interactions often exist to achieve tight control of catalytic activity (23). While
sequestering the activators of Tec kinases at the membrane will ensure that Tec kinase
activation occurs only after the generation of lipid second messengers (39,42), it does not
preclude the existence of additional modes of negative regulation.
All of the Tec kinases exhibit intermolecular self-association via their non-catalytic
regulatory domains. Btk, Tec, and Txk fragments self-associate through classical SH3/
proline interactions (28,70,71), while for Itk, the SH3 and SH2 domains interact in a manner
that mediates intermolecular self-association (90). In addition to SH3-mediated
intermolecular self-association, the Itk PH domain also interacts with itself in an
intermolecular fashion (51), and the structure of the Btk PH domain reveals a dimeric
arrangement (25). The molecular details of PH domain self-association in solution are not
yet known, but it seems likely that intermolecular contacts across the entire regulatory
region of the Tec kinases serve to stabilize the self-associated form. We next consider
whether these intermolecular domain interactions might impact the activation status of the
kinase domain itself.
In considering the functional implications of intermolecular domain interactions among the
Tec kinases, the observations of domain fragment interactions (28,51,70,71,90) must first be
extended to full-length protein. Along these lines, full length Itk readily co-
immunoprecipitates with itself (51,91). As well, Itk clustering at the T-cell receptor has been
observed upon T-cell activation (127). Building on these observations, we tested in vitro
catalytic activity as a function of Itk enzyme concentration. Notably, we find that for
increasing concentrations of purified Itk, in vitro kinase activity does not increase linearly,
as would be expected for a monomeric enzyme, but kinase activity instead is diminished as
concentration increases suggesting that intermolecular self-association might negatively
influence Itk function (Min L, Andreotti AH, unpublished observations). Further
experiments have indicated that disrupting the SH3/SH2 interaction in the context of full-
length Itk results in a simple linear increase in activity with increasing enzyme
concentration. Thus, we can suggest that formation of self-associated species or Itk clusters
via intermolecular regulatory domain interactions leads to a decrease in catalytic activity.
Mechanistically, several scenarios emerge from this hypothesis. A simple model for Itk
autoinhibition would invoke steric blockage of the catalytic site upon intermolecular self-
association. In fact, small-angle X-ray scattering analysis of full-length unphosphorylated
(inactive) Btk shows a linear arrangement for the regulatory domains (128). Such an
extended conformation could promote oligomerization and maintain Tec kinases in an
inactive state by blocking access to the kinase active site. However, as already discussed, the
isolated Itk kinase domain exhibits little or no catalytic activity by itself (105,106),
suggesting the possibility of a complementary or perhaps alternative autoinhibition
mechanism. Intermolecular self-association of the Itk regulatory domains might compete
with the arrangement of the regulatory domains in the active state of the kinase. In essence,
intermolecular interactions between the PH, SH3, and SH2 domains of distinct Itk molecules
could disfavor activating interactions between the regulatory domains of Itk and the N-
terminal lobe of the kinase domain within the same molecule. The result would be similar to
that observed upon deletion of the non-catalytic domains; intermolecular regulatory domain
interactions pry the SH2 domain and SH2-kinase linker region away from the Itk kinase
domain; the C-helix reverts to the inactive conformation and catalytic activity ceases.
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The stoichiometry of Itk self-association is not known, but several clues now point to
oligomerization rather than a simple monomer/dimer equilibrium. When first characterized
by NMR spectroscopy (90), the SH3-SH2-containing fragment of Itk was considered
primarily dimeric. This conclusion was based on measured linewidths and NMR diffusion
data, both of which would have been weighted toward a dimeric species rather than larger
aggregates, given the inherent line broadening and disappearance of the NMR signal with
increasing molecular weight. More recent work using native gels clearly shows multiple
bands consistent with multiple self-associating species for both the SH3-SH2 fragment of Itk
and the full-length molecule (Joseph RE, Min L, Andreotti AH, unpublished observation).
As well, the recently solved structure of the SH3/SH2 interaction is consistent with
formation of oligomers rather than a simple head-to-tail dimer. The C-terminus of the SH3
domain and the N-terminus of the SH2 domain (location of adjacent SH2 and SH3 domains
in the single polypeptide chains, respectively) protrude on opposite sides of the complex
structure (Fig. 5). Thus, even given full flexibility in the SH3-SH2 linker region, it is
difficult to visualize a head to tail dimer arrangement for this region of Itk.
Mounting evidence points to intermolecular association as a regulatory mode for Itk.
Whether this structural characteristic predominates in resting cells and/or whether
intermolecular contacts are responsible for turning Itk activity off following membrane
proximal signaling is not yet clear. While the inter-molecular interaction between the Itk
SH3 domain and the Itk SH2 domain can mediate oligomerization, the pY binding pocket
remains accessible in the Itk SH3/SH2 complex structure (Fig. 5). It is therefore possible
that the engagement of the Itk SH2 domain with activating phospholigands could disrupt the
Itk SH3/SH2-mediated oligomer favoring Itk activation. A point mutant designed to mimic
autophosphorylation in the Itk SH3 domain (Y180E) leads to a higher affinity for the Itk
SH2 domain. Keeping in mind that this is a mutant protein and not a tyrosine-
phosphorylated protein, it is nevertheless worth considering that autophosphorylation in the
Itk SH3 domain might trigger downregulation by favoring intermolecular domain
associations between different Itk molecules.
Another regulatory layer likely inhibiting the function of the Tec kinases involves
association with exogenous proteins. For example, SAB (SH3 domain-binding protein that
preferentially associates with Btk) and IBtk (inhibitor of Btk) are two proteins that inhibit
the activity of Btk via a direct interaction with the Btk SH3 or PH domains, respectively
(129,130). For Itk, one of the first notions that emerged upon characterization of prolyl
isomerization in the SH2 domain is the possible involvement of the peptidyl prolyl
isomerases in regulating ligand binding and/or catalytic activity. The peptidyl prolyl
isomerases (PPIases) consist of a class of enzymes that catalyze the interconversion between
cis and trans imide bond conformers and have been most widely characterized for their
action on short peptide substrates (131,132).
The extent to which the PPIases, cyclophilin A (CypA) or FKBP (FK506 binding protein),
directly interact with the Itk SH2 domain was originally examined using NMR spectroscopy
(133). Spectral changes were observed upon addition of CypA but not FKBP to the Itk SH2
domain and initial interpretation of the data suggested that CypA catalyzes the slow cis/trans
isomerization based on line broadening (133). Analysis since that time revealed that the
NMR linewidth changes were due instead to paramagnetic impurities associated with the
CypA sample used. Line broadening was reversed upon addition of ethylene diamene
tetraacetic acid to the NMR sample. Even so, chemical shift perturbations in the Itk SH2
domain do arise upon addition of CypA, indicating the presence of an interaction in the
NMR tube.
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Both biochemically and in T cells, Itk function is regulated by the peptidyl prolyl isomerase
CypA (91,133). Specifically, Itk autophosphorylation is diminished in vitro in the presence
of CypA (133), and increased immunoglobulin E levels are seen in CypA knockout mice,
indicative of increased Itk signaling (91). Further functional data suggest that the Itk/SLP-76
interaction is enhanced in CypA-depleted cells and that CypA association with Itk increases
Itk oligomerization (91). All of these pieces of published data point to a regulatory
interaction between Itk and CypA, yet mechanistic insight into just how these proteins
interact and alter signaling remains elusive.
Further observations on CypA and Itk function are allowing us to generate testable
hypotheses regarding the manner in which CypA modulates Itk signaling. In a simple in
vitro kinase assay using purified Itk, we find that CypA has no effect on phosphorylation
kinetics of a short peptide substrate. In contrast, in vitro phosphorylation of a protein
substrate is diminished in the presence of CypA (Xu R, Andreotti AH, unpublished
observations), consistent with the decreased autophosphorylation of Itk observed in the
presence of CypA (133). These findings suggest that CypA does not alter the kinase activity
of Itk per se but might rather inhibit accessibility to physiological substrates. Whether CypA
directly affects the substrate docking mechanism we have described above or elicits an
effect on protein substrates by another means remains to be determined.
Bringing the conformational snapshots together
Structural biology plays an important role in elucidating regulatory mechanisms of signaling
proteins. Ultimately, structural approaches combined with biochemistry, genetics, and cell
biological approaches will lead to a full appreciation of the interplay between the intra- and
intermolecular interactions that control Tec kinase function. In this review, we have brought
together the available pieces of structural knowledge to begin to make sense of the complex
regulatory features of this family of immunological kinases. The salient features of the
preceding figures and discussion are summarized in Fig. 11.
The non-catalytic regulatory domains of Itk and family members participate in a number of
canonical and non-canonical interactions that control both activation and sequestration of
Tec kinase activity during signaling. One of the first non-classical interactions identified for
Itk involves the intermolecular interaction between the SH3 and SH2 domain. This protein-
protein interaction makes use of the unusual cis prolyl imide bond conformation in the SH2
domain and appears to contribute to intermolecular clustering of full length Itk (Fig. 11A).
Biochemical data indicate that increased Itk clustering leads to a decrease in catalytic
activity. As well, mutation of the conformationally heterogeneous proline in Itk to a residue
that cannot access the cis imide bond conformation leads to an increase in IL-4 production in
wild type mice (91), possibly due to a shift in equilibrium away from the self-associated
state. Thus, we propose that the inactive state of Itk consists, at least in part, of self-
associated molecules that either serve to decouple the regulatory domains from the kinase
domain or sterically block the kinase active site or both. Furthermore, the negative
regulatory effect of CypA might be to stabilize the self-associated form or block access to
substrate or both (Fig. 11A).
Crystals structures of the isolated Tec family kinase domains along with extensive kinetic
characterization of mutants and deletion fragments suggest that like the Csk tyrosine kinase,
the SH3-SH2 cassette and adjacent linker regions of the Tec kinases are required to stabilize
the active state of the kinase domain (Fig. 11B). Triggering the switch between the resting
state and this activated state could be PH domain association with membrane lipids, binding
of transient phospholigands to the SH2 domain (this competes directly with the SH3/SH2
intermolecular interaction), and of course phosphorylation of the Tec kinase activation loop
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tyrosine by Src family kinases. Upon activation, the Tec kinases engage the SH2 domain of
their target substrates (via a non-canonical interaction interface) to achieve specificity in the
phosphorylation reaction. It will be interesting to ascertain just how the Itk kinase domain,
for example, is activated by its adjacent regulatory region and at the same time docks onto
the SH2 domain of downstream substrates.
In addition to downstream Tec substrates that carry the activation signal forward, the Tec
kinases autophosphorylate a conserved tyrosine in their own SH3 domain (Fig. 11C). In
putting these pieces of information into context, it is interesting to note that Wilcox and
Berg (56) show that the Itk Y180F mutant can still be phosphorylated on Y511 in Sf9 cells,
yet the Itk Y511F mutant is not phosphorylated on Y180. These data, perhaps not
surprisingly, suggest that Y511 phosphorylation (Itk activation) occurs prior to
autophosphorylation. How then does autophosphorylation fit into the signaling cascade?
Autophosphorylation clearly serves to fine tune ligand binding of the SH3 domain. Another
possibility is that phosphorylation of Y180 in Itk is a step toward inactivation of Itk. The
enhanced affinity between the Itk SH3 and SH2 domains that might result from
phosphorylation on Y180 would shift the ensemble of Itk molecules toward the self-
associated state. As well, in cis SH2-mediated substrate docking required to
autophosphorylate the SH3 domain might displace exogenous ligands. Certainly additional
factors will be at work as the Tec kinases are ‘turned off’, such as phosphatase activity
leading to the disappearance of the phospholigands that bind the SH2 domain, diminished
membrane association due to the action of lipid phosphatases, and dephosphorylation of the
activation loop tyrosine.
The next step to advance our knowledge in this area will be crystallization of multidomain
fragments and/or the full-length Tec kinases. High-resolution structures of members of the
Tec kinases as well as enzyme/substrate complexes of Tec kinases are eagerly awaited.
These structures will be key to testing the proposed activation models and for unraveling the
precise mechanisms underlying Tec kinase regulation.
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Fig. 1. Tec family kinase domain structures
(A) The Tec kinases consist of a pleckstrin homology (PH) domain, a Tec homology (TH)
domain that contains both the Btk motif and a proline-rich region (PRR), SH3, SH2, and
kinase domains. (B-E) Individual domain structures. Ligands for each domain are shown in
blue. Dotted lines connect the N- and C-termini of consecutive domains. A structure of a full
length Tec kinase is not available, and so the precise spatial relationship between domains is
not known. (B) Crystal structure of the PH-TH region of Btk (pdb: 1b55) complexed with
inositol-1,3,4,5-tetrakisphosphate (IP4). The Btk motif (orange) consists of an extended loop
structure that is held in place by a coordinated zinc ion (teal sphere). (C) Itk SH3 domain
bound to a proline-rich ligand (pdb: 1awj). The proline-rich peptide ligand (KPLPPTP)
adopts a left handed helical conformation and contacts the SH3 domain binding groove via
hydrophobic and electrostatic interactions. (D) Itk SH2 domain bound to a phosphotyrosine-
containing peptide ligand (pdb: 2etz). Classical SH2 ligand binding consists of a two-
pronged interaction involving a phosphorylated tyrosine side chain (pY) contacting a basic
binding pocket on the SH2 domain that contains at least one conserved arginine and a ligand
residue three positions removed from the phosphotyrosine (pY+3) that contacts a specificity
pocket on the SH2 domain. (E) Structure of the Itk kinase domain bound to staurosporine, an
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inhibitor that binds to the ATP binding site (pdb: 1snu). The kinase domain consists of two
lobes, the smaller N-terminal lobe and the larger C-terminal lobe. Catalysis occurs in the
binding cleft (labeled active site) between these two lobes. All structures in this and other
figures were generated using PyMOL (134).
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Fig. 2. Btk PH domain: electrostatic potential
IP4 (shown in red sticks) bound to the Btk PH domain. The PH domain surface is colored to
indicate electrostatic potential; the large concentration of positive charge (indicated in blue
and circled) coincides with the IP4 binding site.
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Fig. 3. Location of the autophosphorylation site within the SH3 ligand binding site
The Itk SH3 domain bound to the classical proline rich peptide ligand (shown in blue
sticks). Y180 (the Itk autophosphorylation site) is indicated in red on the brown SH3 domain
surface. Y180 sits at the edge of the ligand-binding site and, when mutated to glutamate (to
mimic phosphorylation), induces structural changes that extend into the ligand binding cleft
(indicated with arrow). SH3 ligand binding affinities are altered by this phopho-mimicking
mutation (66).
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Fig. 4. Conformational heterogeneity in the Itk SH2 domain
(A) The Itk SH2 domain structure reveals a single proline residue (Pro 287) that
interconverts between the cis and trans imide bond conformations in solution. Pro 287 is
located at the base of a large loop (the CD loop using standard SH2 domain nomenclature).
In the trans imide bond containing SH2 conformer (right), the CD loop is extended and
flexible; in contrast, the CD loop in the cis structure (left) is more rigid and adopts a
conformation that bends toward the body of the SH2 domain (32). The differences in loop
flexibility between the cis and trans structures are evident in independent dynamics
measurements using NMR spectroscopy (32). (B) The conformational heterogeneity induced
by prolyl isomerization in the Itk SH2 domain causes structural differences (as measured by
NMR) across nearly half of the domain surface. The lighter shading represents SH2 residues
that give rise to doubled resonances in NMR spectra of the domain due to slow
interconversion between the cis and trans peptide bond between residues 286 and 287.
Doubled resonances are indicative of two different structural environments for each
particular residue in the cis and trans structures. Darker surface are those regions that are
unaffected by prolyl isomerization. It is noteworthy that classical phosphopeptide binding is
affected by isomerization (89). On the top structure, the bound phospholigand is included,
and it is clear that the pY binding pocket is not affected by proyl isomerization in the CD
loop. The BG loop that makes up one side of the pY+3 pocket (circled), however, is
influenced by prolyl isomerization explaining how phospholigand binding discriminates
between the two structures despite its distance from Pro 287 (labeled and highlighted in
cyan) (80).
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Fig. 5. The non-canonical Itk SH3/Itk SH2 interaction
(A) The Itk SH3 domain (brown) binds to the Itk SH2 domain (cyan) via the conserved SH3
binding site despite the absence of a classical proline rich ligand sequence in the Itk SH2
domain. Three SH2 loops (EF, BG, and CD) make contact to the SH3 domain and the CD
loop in particular is pre-organized for binding the SH3 domain by the cis imide bond at Pro
287. The trans imide bond-containing SH2 conformer is shown in black (the CD loop is
shown while the rest of the trans SH2 structure is omitted for clarity). The conformation of
the CD loop in the trans structure does not permit contacts between this part of the SH2
domain and the SH3 binding surface. The conserved arginine in the phosphotyrosine (pY)
binding pocket is indicated in red and is sterically accessible in the SH3/SH2 complex. (B)
Surface rendering of the same view of the SH3/cisSH2 complex.
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Fig. 6. Tec family kinase domain structure and active site residues
Superposition of the unphosphorylated kinase domain of Btk (1k2p) in blue with the
phosphorylated kinase domain of Lck (3lck) in grey. Yellow side chains are those of Btk
and red side chains are from Lck. The conserved activation loop tyrosine is phosphorylated
within Lck (labeled pY394) and unphosphorylated in the Btk structure. The active site
details are shown in the expanded view on the right. The position of the conserved lysine
within each kinase domain and the glutamate on the C-helix is indicated. Activation of the
kinase requires the critical ion pair between lysine and glutamate and the position of the C-
helix determines the distance between these side chains.
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Fig. 7. Comparison of the full length Csk structure with the Itk kinase domain structure
Superposition of the Itk kinase domain (blue) with full-length active Csk (1snx and 1k9a,
respectively). The Csk kinase domain is gray, and the Csk SH3 and SH2 domains are
colored brown and labeled. The linker between Csk SH3 and SH2 domains is red and the
Csk SH2-kinase linker region is colored green. The expanded view shows the details of Csk
activation by the SH3-SH2 and SH2-kinase linkers. Side chains that stabilize the active
conformation of the C-helix [M410 (of Itk) and W188 (of Csk)] are shown in gold sticks.
The position of the Itk W355 is predicted to be in the same location as that of Csk W188.
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Fig. 8. Peptide substrate recognition
A detailed view of the active site of insulin receptor kinase (Irk) shows a peptide substrate,
containing the sequence YMNM (orange) forming an anti-parallel β sheet with the
activation loop of the kinase (labeled and indicated by dashed box). The kinase is colored
green and depicted with ribbons. The tyrosine (Y) and two methionines (M) of the peptide
substrate are labeled. The Irk active site also contains the non-hydrolyzable ATP analog
adenylyl diphosphate (AMP-PNP), depicted with sticks and colored red. The C-helix of the
N-terminal kinase lobe is labeled.
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Fig. 9. Itk substrate recognition model: PLC
γ1. A direct interaction between the Itk kinase domain and the SH2 domain of PLCγ1
mediates specific phosphorylation of Y783 in PLCγ1. The docking interface consists of a
cluster of basic residues on the PLCγ1 SH2 domain that do not overlap with the classical
phosphotyrosine-binding functions of the SH2 domain and an as yet undetermined surface
on the Itk kinase domain. We speculate docking occurs on the N-terminal lobe (labeled N-
lobe) based on a potentially complementary cluster of acidic residues in this region. The Itk
kinase domain is depicted here as a surface representation and the PLCγ1 SH2 domain
structure (pdb 2pld) is show with ribbons (brown). SH2 interface residues identified by
mutation are indicated in blue. SH2-bound phosphopeptide is shown (cyan) and would be
compatible with the proposed docking model. The C-terminus of the PLCγ1 SH2 structure is
labeled (C), and the model suggests that Y783 would be positioned into the active site as
indicated by the arrow.
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Fig. 10. Itk autophosphorylation model
(A) The Itk kinase domain (1snx), depicted in brown ribbons, was superimposed with the Irk
structure (1irk). As already shown in Fig. 8, the Irk structure includes a peptide substrate and
the non-hydrolyzable ATP analog AMP-PNP. For clarity, only the Itk kinase domain
structure, AMP-PNP (in blue), and the Irk peptide substrate (in orange) are shown. Next, the
side chain of the Itk autophosphorylation tyrosine (Y180 shown in red) within the Itk SH3
domain was superimposed with the substrate tyrosine of the YMNM peptide in the Irk
structure. The Itk SH3 domain (in light brown) was not further adjusted within the active
site. The proximity of the βA strand of the SH3 domain and the Irk peptide substrate is
evident in the model. The activation loop is not defined in the Itk kinase domain structure.
The predicted Itk SH2 domain docking site is circled. (B) Surface rendering of the same
model shown in (A). The excellent fit of the Itk SH3 domain in the active site cleft of Itk is
evident in this representation. As in (A), the ATP analog is depicted in blue and Y180 in the
SH3 domain is red.
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Fig. 11. Conformational snapshots of Itk signaling
Cartoon depiction of the Itk regulatory apparatus. (A) Intermolecular self-association of the
Tec family regulatory domains suggest that these kinases might cluster or oligomerize
within the cell. For Itk, the intermolecular interactions consist of the SH3/SH2 complex
[structure shown in inset (see also Fig. 5); corresponding region is boxed on cartoon] as well
as biochemical data showing PH domain self-association (indicated by double headed dotted
arrow). Building from the SH3/SH2 structure, a cartoon representation of oligomerized Itk is
shown. Individual molecules of Itk are colored differently (blue, brown, green), and the
possibility of larger clusters is indicated on both sides. The SH2-SH3 linker region is
colored red, and the SH2-kinase linker is green (corresponding to color scheme in Fig. 7).
The kinase active site is labeled on one subunit of the oligomer, and CypA is included to
represent its putative regulatory interaction with Itk. The orange oval bound to one of the PH
domains indicates the possible role of IP4 in regulating Itk signaling. (B) A number of
activating signals upon receptor engagement have been well described and are listed above
the arrow going from (A) to (B). The cartoon representation of Itk in (B) then depicts the
possible conformation and location of active Itk. A monomeric Itk is shown, but the actual
aggregation state of Itk at the membrane (whether still partially or wholly self-associated) is
not known. PH domain binding to phospholipids generated by PI3K brings Itk to the
membrane where the enzyme is co-localized with activating signals from Slp76, LAT and
Lck. Phospholigand bound to the SH2 domain is shown. The SH3-SH2-kinase region is
boxed and the corresponding Csk structure after which the cartoon is modeled is shown in
the inset (see also Fig. 7). Biochemical data suggest that Tec kinases (like Csk) are
positively regulated by their regulatory domains; in particular the SH2 and SH2-kinase
linker regions. This linker (shown in green) packs against the small lobe of the kinase
positioning the C-helix appropriately for catalytic activity to commence. Substrate
recognition via SH2 docking onto the Itk kinase domain is indicated for the PLCγ1 substrate
of Itk (gray). Location of substrate docking on the Itk kinase domain in not known and is
therefore intentionally shown in a position that is different from that depicted in Fig. 9. (C)
In cis autophosphorylation of Y180 in the Itk SH3 domain is depicted. The structural model
of Y180 phosphorylation (based on the Irk crystal structure complexed with a short peptide
substrate; see Fig. 10) is shown in the inset and the corresponding kinase/SH3 portion of the
cartoon is boxed. Intramolecular SH2 docking is required for autophosphorylation. The
possibility that phosphorylation on Y180 might shift Itk toward the self-association state is
discussed in the text.
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